Press release content from Business Wire. The AP news staff was not involved in its creation.
UKONIQ™ (umbralisib) Now Approved by the FDA; Onco360® Selected as Exclusive Specialty Pharmacy Partner
February 8, 2021 GMT
LOUISVILLE, Ky. (BUSINESS WIRE) Feb 8, 2021
Onco360 ®, the nation’s largest independent Oncology Pharmacy, has been selected by TG Therapeutics, Inc. to be the exclusive specialty pharmacy partner for UKONIQ TM (umbralisib), a new oral treatment for adult patients with relapsed refractory marginal zone lymphoma who have received at least one prior anti-CD20-based regimen and relapsed refractory follicular lymphoma who have received at least three prior lines of systemic therapy. These indications are approved under accelerated approval based on overall response rate. Continued approval for these indications may be contingent upon verification and description of clinical benefit in a confirmatory trial.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Humana and Roche Settle False Claims Act Lawsuit for $12.5 Million
Sanford Heisler Sharp LLPFebruary 8, 2021 GMT
NEW YORK, Feb. 08, 2021 (GLOBE NEWSWIRE) Sanford Heisler Sharp, LLP announced that Indianapolis-based Roche Diagnostics Corp. and Roche Diabetes Care, Inc. (“Roche”) and Louisville-based Humana, Inc., Humana Pharmacy, Inc., and Humana Pharmacy Solutions, Inc. (“Humana”) have agreed to settle a False Claims Act lawsuit brought by a whistleblower relator (“Relator”) on behalf of the United States. Defendants will pay $12.5 million to settle the government’s claims, and the Relator will receive a 29% share of the settlement, totaling $3,625,000.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
111, Inc. Signs Strategic Cooperation Agreement with Jilin Baiyi Doctor Group to Create & Deliver New Models for Internet Medical Services
February 5, 2021 GMT
SHANGHAI, Feb. 5, 2021 /PRNewswire/ On January 11, 2021, 111, Inc. (“111” or the “Company”) (Nasdaq: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, and Jilin Baiyi Doctor Group Management Co., Ltd. (“Baiyi Doctor Group”), owner of the largest doctor group in China’s Jilin province, have entered into a strategic partnership where the companies will leverage the unique capabilities of 111′s digital platform to provide SMART-enabled healthcare services and doctor-patient management in Northeast China.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Humana Selected by Oklahoma Health Care Authority to Serve Medicaid Beneficiaries
January 29, 2021 GMT
OKLAHOMA CITY (BUSINESS WIRE) Jan 29, 2021
Leading health and well-being company Humana Inc. (NYSE: HUM) has been selected by the Oklahoma Health Care Authority (OHCA) to deliver health care coverage to Medicaid beneficiaries across the state, starting later this year. Humana’s Medicaid division, Humana Healthy Horizons, will administer the coverage in Oklahoma.
ADVERTISEMENT
Through SoonerSelect, the Oklahoma Medicaid managed care program – focused on Temporary Assistance for Needy Families, the Children’s Health Insurance Program, and Medicaid Expansion populations – Humana will serve children and adults across the state with the goal of improving their health and well-being.